The Compression Therapy Devices Market to walk through digitized destiny
The Compression Therapy Devices Market is all set to be in the driver’s seat shortly. Technology
adoption once looked upon as a costly endeavor, is slated to witness a drastic transformation in the
form of granular applications. Technologies like DevOps and AIOps are constructively disrupting the
healthcare IT sector and are expected to create wonders in this regard in the upcoming period.
According to a new market report published by Persistence Market Research “Global Market Study
on Compression Therapy – Asia to Witness Highest Growth by 2020”, the global compression
therapy market was valued at USD 2,377.8 million in 2014 and is expected to expand at a CAGR of
5.2% from 2014 to 2020, to reach USD 3,232.3 million by 2020.
Compression therapy is a procedure entailing the delivery of an external force to tired and aching
legs and other relevant anatomical targets where compression is required for management. This
therapy is used to treat venous and lymphatic diseases such as lower limb edema, venous eczema,
deep vein thrombosis, and diabetic foot ulcers.
How About Looking Through The Sample Of Compression Therapy Devices Market
Some of the major players in the compression therapy market:
BSN medical GmbH.
PAUL HARTMANN AG.
Julius Zorn GmbH.
Smith & Nephew plc.
medi GmbH & Co. KG.
Globally, the market for compression therapy is witnessing significant growth due to the increasing
prevalence of diabetes, growth of the aging population, high incidence of sports injuries, rising
awareness about various venous diseases, and the advanced features of compression therapy
garments and devices.
However, inadequate reimbursement policies and the risk of complications associated with
compression therapy systems inhibit the growth of the market. The global compression therapy
market is anticipated to grow from an estimated USD 2,377.